BRUSSELS/FRANKFURT/PARIS (dpa-AFX) - Mitsui & Co., Ltd. has decided to
acquire shares in Eu Yan Sang International Ltd jointly with ROHTO
Pharmaceutical Co. Based in Singapore, EYS manufactures and sells traditional
Chinese medicines. The acquisition of 100% of EYS shares is valued at
approximately 88 billion yen.

A special purpose company, jointly owned by Mitsui and Rohto, will acquire
approximately 86% of the EYS shares from Righteous Crane Holding, pursuant to a
conditional sale and purchase agreement. Upon fulfillment of the condition in
the SPA, a takeover bid for the remaining 14% of EYS shares will be executed and
the founding family of EYS will reinvest partially into the special purpose
company. Mitsui will acquire shares worth an estimated 15 billion yen on a net
basis, excluding the proceeds from the RCH's sale of the EYS shares.



Copyright(c) 2024 RTTNews.com. All Rights Reserved

Copyright RTT News/dpa-AFX